Your browser doesn't support javascript.
loading
Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
Beebeejaun, Kazim; Parikh, Sydel R; Campbell, Helen; Gray, Steve; Borrow, Ray; Ramsay, Mary E; Ladhani, Shamez N.
Afiliación
  • Beebeejaun K; Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.
  • Parikh SR; Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.
  • Campbell H; Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.
  • Gray S; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Borrow R; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Ramsay ME; Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.
  • Ladhani SN; Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom; Paediatric Infectious Diseases Research Group (PIDRG), St. George's University of London, Cranmer Terrace, London SW17 0RE, United Kingdom. Electronic address: shamez.ladhani@phe.go
J Infect ; 80(3): 286-290, 2020 03.
Article en En | MEDLINE | ID: mdl-31904388
ABSTRACT

BACKGROUND:

Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia, with death often occurring rapidly after onset of the first symptoms. Later death can also occur, but may be due to other causes, such as underlying comorbidities. The study aimed to assess the timing and cause of death in patients with invasive meningococcal disease (IMD) prior to the introduction of two new meningococcal immunisation programmes in England.

METHODS:

Public Health England (PHE) conducts IMD surveillance in England through its national meningococcal reference unit. Laboratory-confirmed IMD cases diagnosed during 2008-2015 were linked to weekly and annual electronic death registration records as well as the Patient Demographic Service (PDS) database.

RESULTS:

Overall, 6734 of 6808 (99%) laboratory-confirmed IMD cases matched to PDS, including 668 fatalities. Of these, 667 linked to an annual death registration record compared to 405 reports linked to weekly death registrations. In total, 429/667 (64%) of all deaths and 428/502 (85%) of IMD-related deaths occurred within one day of diagnosis. In total, 498/667 (75%) deaths had occured by 30 days after IMD diagnosis and 98% (490/498) of these were IMD-related. Serogroup B contributed to 64% (323/502) of IMD-related deaths, followed by serogroup W (84/502, 17%) and serogroup Y (70/502, 14%). Deaths occurring after 30 days were less likely to be IMD-related, mainly amongst ≥65 year-olds, with malignancy, chronic respiratory and cardiac conditions predominating.

CONCLUSIONS:

Most IMD-related deaths occurred within a day of diagnosis and nearly all IMD-related deaths occurred within 30 days of diagnosis. The rapidity of death highlights the importance of prevention through vaccination.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Meningococicas / Meningitis Meningocócica / Infecciones Meningocócicas / Neisseria meningitidis Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Humans / Infant País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Meningococicas / Meningitis Meningocócica / Infecciones Meningocócicas / Neisseria meningitidis Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Humans / Infant País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido